BBIO•benzinga•
The Medicines And Healthcare Products Regulatory Agency Has Approved BridgeBio Pharma's Acoramidis, Under The Brand Name Beyonttra, For Wild-type Or Variant Transthyretin Amyloidosis In Adult Patients With Cardiomyopathy
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2025 by benzinga